You are here : Home > I2BM > Presentation of Institut of Biomedical Imaging

Basic info on...

Institute of biomedical imaging (I²BM)

Published on 19 October 2015

The research done by the Institute along two main lines:

  • Methodological developments including the physics of Magnetic Resonance Imaging (MRI), the optimization of data acquisition and processing protocols for Positron Emission Tomography (PET), development of tracers for PET Imaging and for multimodality PET - MRI - optical imaging and image processing and development of associated software architectures.
  • Preclinical and clinical research mostly in the fields of neuroscience and oncology

The Biomedical imaging institute (i²bm) gathers cutting edge imaging facilites



A facility exploiting ultra-high field MRI - 3T, 7T and a future 11.7T for human, and 7T and 17.2T for small animal imaging and magneto-encephalography (MEG) for detection of the brain low magnetic fields, for brain studies.

​Service hospitalier Frédéric Joliot

A facility for molecular imaging using PET, PET/CT, PET/MR and SPECT imaging. This platform is associated with the Orsay-Lonjumeau hospital.


A platform for translational research dedicated to the development of gene, cellular and drug based therapies for neurodegenerative and infectious diseases. This platform associates imaging, virology and animal models of human diseases.


The institute is also involved in the set-up and the exploitation of the PET imaging and radiochemistry platform of the GIP Cycéron in Caen.